Over the 3 to 12 months following catheter ablation, patients who received metformin had greater freedom from recurrent ...

NEW ORLEANS, LA—Sodium-glucose cotransporter 2 (SGLT2) inhibition does not seem to be a solution to the problem of arrhythmia ...

OCEAN was an open-label trial conducted in Australia, Belgium, Canada, China, Germany, and Israel. Eligible participants had ...

A minimally invasive heart procedure to correct irregular heart rhythms called catheter ablation may reduce the risk of ...

Adults with atrial fibrillation with overweight or obesity were less likely to experience recurrent atrial arrhythmia when ...

Aggressive lifestyle and risk factor control after ablation significantly lowers atrial fibrillation recurrence and improves ...

Background: Observational studies have suggested that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a lower risk of atrial fibrillation (AF) recurrence after catheter ablation ...

Background Pulsed field ablation (PFA) has emerged as a promising non-thermal alternative to conventional atrial fibrillation ...

Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

Boston Scientific (NYSE: BSX) today announced a catheter development and commercialization deal with Siemens Healthineers.

The company also posted weaker third-quarter results, but CEO David Fischel said orders for the new GenesisX system, when ...

Successful catheter ablation resulted in a low risk of stroke associated with atrial fibrillation (AFib), a type of irregular ...